Mesothelioma Research | Science Advisory Board | Kenneth Rozenzweig, MD

The Meso Foundation’s Science Advisory Board strives to be a source of change and hope for mesothelioma patients and their families. Constituted of world-renowned mesothelioma experts, our goal is to help find and advance the leading mesothelioma and asbestos research projects. Additionally, our objective is to continue to provide educational information and resources to patients and healthcare providers about the latest advances in mesothelioma research.

Among those on our board of mesothelioma and asbestos research experts is Dr. Kenneth Rozenzweig.

Meet Kenneth Rozenzweig, MD

Mesothelioma Research Experts: Kenneth Rozenzweig, MD

Dr. Rosenzweig is Associate Member of the Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center and in New York, New York. His clinical expertise is in treating cancers of the chest including mesothelioma, non-small cell lung cancer, small cell lung cancer, and thymoma. Dr. Rosenzweig’s research involves adapting the latest technology to allow for safer, more aggressive radiation therapy for lung cancer, such as intensity modulated radiation therapy. He has been a principle investigator on multiple trials evaluating the use of radiation therapy for mesothelioma and lung cancer.

Contact Info for Kenneth Rozenzweig, MD
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10065


Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376